CHARLOTTE, N.C., May 14, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company…
NYSE issues a pre-market daily advisory direct from the trading floor.NEW YORK, April 9, 2026 /PRNewswire/ -- The New York…
Full year fiscal 2025 net income of $328,161,370 Full year fiscal 2025 fully diluted EPS of $13.39 per shareBMNR to…